Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Geron	Molecular Templates	Spectrum Pharmaceuticals	Viking Therapeutics	Forte Biosciences
Symbol	NASDAQ:GERN	NASDAQ:MTEM	NASDAQ:SPPI	NASDAQ:VKTX	NASDAQ:FBRX
Price Information
Current Price	$1.33	$8.81	$3.08	$5.90	$32.64
52 Week Range	Buy	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.4	2.0	1.5	1.6	1.7
Analysis Score	3.5	3.4	3.4	3.6	3.5
Community Score	2.7	2.6	2.8	3.5	3.5
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	3.3	0.8	0.8	0.8
Earnings & Valuation Score	0.0	0.6	0.6	0.0	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$4.20	$14.50	$9.75	$16.89	$82.00
% Upside from Price Target	215.79% upside	64.59% upside	216.56% upside	186.25% upside	151.23% upside
Trade Information
Market Cap	$423.65 million	$494.14 million	$479.60 million	$460.79 million	$441.03 million
Beta	1.5	2.08	2.51	2.02	0.23
Average Volume	3,335,652	443,700	2,600,056	1,280,241	176,442
Sales & Book Value
Annual Revenue	$460,000.00	$22.27 million	$109.33 million	N/A	$40,000.00
Price / Sales	920.97	22.19	4.39	N/A	11,025.79
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$0.68 per share	$2.79 per share	$1.69 per share	$3.83 per share	$6.81 per share
Price / Book	1.96	3.16	1.82	N/A	4.79
Profitability
Net Income	$-68,550,000.00	$-69,420,000.00	$-112,690,000.00	$-25,780,000.00	$-63,520,000.00
EPS	($0.36)	($1.26)	($1.14)	($0.36)	($40.33)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-21,631.02%	-428.65%	N/A	N/A	N/A
Return on Equity (ROE)	-43.76%	-111.43%	-98.90%	-13.57%	-417.87%
Return on Assets (ROA)	-37.24%	-56.35%	-69.77%	-13.14%	-248.28%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.10%	0.18%	0.05%	N/A	N/A
Current Ratio	9.60%	3.21%	3.48%	27.08%	8.97%
Quick Ratio	9.60%	3.21%	3.48%	27.09%	8.97%
Ownership Information
Institutional Ownership Percentage	55.51%	60.73%	63.56%	54.13%	53.03%
Insider Ownership Percentage	7.70%	38.20%	5.04%	3.70%	10.90%
Miscellaneous
Employees	53	228	175	18	9
Shares Outstanding	318.53 million	56.09 million	155.71 million	78.10 million	13.51 million
Next Earnings Date	5/10/2021 (Confirmed)	5/10/2021 (Estimated)	5/13/2021 (Confirmed)	8/4/2021 (Estimated)	5/10/2021 (Confirmed)
Optionable	Optionable	Not Optionable	Optionable	Optionable	Not Optionable

Source	Headline
	-$0.39 Earnings Per Share Expected for Forte Biosciences, Inc. (NASDAQ:FBRX) This Quarter americanbankingnews.com - May 7 at 3:14 AM
	Forte Biosciences, Inc. (NASDAQ:FBRX) Expected to Post Earnings of -$0.39 Per Share americanbankingnews.com - May 7 at 3:14 AM
	Forte Biosciences, Inc. (NASDAQ:FBRX) Receives Consensus Recommendation of "Buy" from Analysts americanbankingnews.com - May 5 at 10:55 AM
	Forte Biosciences (FBRX) Set to Announce Earnings on Monday americanbankingnews.com - May 4 at 12:04 PM
	Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update finance.yahoo.com - May 3 at 5:47 PM
	Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Up 27.9% in April americanbankingnews.com - May 3 at 12:22 PM
	Forte Biosciences (NASDAQ:FBRX) Stock Price Up 4.4% americanbankingnews.com - April 28 at 12:38 PM
	Forte Posts Lower-Than-Feared Quarterly Loss; Shares Drop 9.5% finance.yahoo.com - March 25 at 10:09 AM
	Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results and Provides a General Business Update finance.yahoo.com - March 24 at 9:04 AM
	Forte Biosciences, Inc. (37TA.F) sg.finance.yahoo.com - March 18 at 10:04 AM
	Forte Biosciences, Inc. to Announce 4Q and Full Year 2020 Results and Provide a General Business Update finance.yahoo.com - March 17 at 6:17 PM
	Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th finance.yahoo.com - February 23 at 6:10 PM
	Forte Biosciences, Inc. to Present at the Cowen Annual Health Care Conference on March 1 st businesswire.com - February 18 at 8:23 PM
	Forte Biosciences, Inc. to Present at the Cowen Annual Health Care Conference on March 1st finance.yahoo.com - February 18 at 8:23 PM
	What Kind Of Investors Own Most Of Forte Biosciences, Inc. (NASDAQ:FBRX)? finance.yahoo.com - February 13 at 1:05 PM
	A Top Biotechnology Play for 2021 realmoney.thestreet.com - January 19 at 4:56 PM
	Forte Biosciences Inc. (FBRX) realmoney.thestreet.com - January 16 at 12:27 AM
	Forte Biosciences: FB-401 Potentially Best-In-Class In Atopic Dermatitis seekingalpha.com - December 19 at 11:22 PM
	Is Forte Biosciences (FBRX) A Good Stock To Buy Now? finance.yahoo.com - December 3 at 1:56 AM
	Forte Biosciences, Inc. to Present at the Evercore ISI 3rd Annual HealthCONx Conference on December 3rd finance.yahoo.com - November 24 at 7:50 PM
	Read This Before Selling Forte Biosciences, Inc. (NASDAQ:FBRX) Shares finance.yahoo.com - November 15 at 9:23 AM
	Forte Biosciences, Inc. to Present at the Stifel 2020 Virtual Healthcare Conference on November 18 th businesswire.com - November 11 at 5:40 PM
	Forte Biosciences, Inc. to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th finance.yahoo.com - November 10 at 5:57 PM
	Forte Biosciences Inc to Host Earnings Call finance.yahoo.com - November 9 at 6:30 PM
	Forte Biosciences, Inc. Announces Third Quarter 2020 Results and Provides General Business Update finance.yahoo.com - November 9 at 6:30 PM

Date	Company	Brokerage	Action
4/8/2021	Geron	HC Wainwright	Reiterated Rating
2/17/2021	Geron	B. Riley	Reiterated Rating
8/3/2020	Geron	Stifel Nicolaus	Initiated Coverage
6/17/2020	Geron	Needham & Company LLC	Reiterated Rating
6/1/2020	Geron	Cantor Fitzgerald	Boost Price Target
4/3/2020	Geron	BTIG Research	Lower Price Target
9/27/2018	Geron	S&P Equity Research	Lower Price Target
7/5/2018	Geron	(FBRC)	Initiated Coverage
4/27/2021	Molecular Templates	Bank of America	Initiated Coverage
4/15/2021	Molecular Templates	Oppenheimer	Lower Price Target
4/6/2021	Molecular Templates	Jefferies Financial Group	Boost Price Target
2/1/2021	Molecular Templates	UBS Group	Initiated Coverage
2/27/2020	Molecular Templates	Barclays	Initiated Coverage
11/13/2019	Molecular Templates	Cowen	Reiterated Rating
12/11/2018	Molecular Templates	CIBC	Initiated Coverage
12/10/2018	Molecular Templates	LADENBURG THALM/SH SH	Reiterated Rating
11/15/2018	Molecular Templates	Evercore ISI	Initiated Coverage
10/8/2018	Molecular Templates	Laidlaw	Initiated Coverage
9/17/2020	Spectrum Pharmaceuticals	JMP Securities	Initiated Coverage
12/26/2019	Spectrum Pharmaceuticals	Guggenheim	Downgrade
5/3/2021	Viking Therapeutics	SVB Leerink	Reiterated Rating
10/29/2020	Viking Therapeutics	Raymond James	Boost Price Target
9/11/2020	Viking Therapeutics	William Blair	Reiterated Rating
8/31/2020	Viking Therapeutics	Chardan Capital	Boost Price Target
6/4/2020	Viking Therapeutics	BMO Capital Markets	Initiated Coverage
5/2/2020	Viking Therapeutics	Maxim Group	Initiated Coverage
4/1/2021	Forte Biosciences	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Initiated Coverage
8/28/2020	Forte Biosciences	Brookline Capital Management	Initiated Coverage
8/25/2020	Forte Biosciences	Truist Securiti	Initiated Coverage

(Data available from 5/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources